Oregon Public Employees Retirement Fund’s Seres Therapeutics MCRB Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio MCRB Stock Details MCRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,464	Closed	-$636K	–	1561
2022 Q1	$636K	Hold	4,464	–	–	0.01%	1306
2021 Q4	$744K	Hold	4,464	–	–	0.01%	1150
2021 Q3	$621K	Hold	4,464	–	–	0.01%	1227
2021 Q2	$2.13M	Hold	4,464	–	–	0.02%	599
2021 Q1	$1.84M	Hold	4,464	–	–	0.02%	630
2020 Q4	$2.19M	Buy	+4,464	New	+$2.61M	0.03%	497

Other funds holding MCRB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

Oregon Public Employees Retirement Fund's MCRB Position: Q2 2022 in Review

Oregon Public Employees Retirement Fund sold out of Seres Therapeutics (MCRB) in Q2 2022, closing a stake of 4,464 shares — an estimated $636K sold.

Oregon Public Employees Retirement Fund first reported a position in MCRB in Q4 2020 and held it in 6 quarters. The position peaked at $2.19M in Q4 2020. 123 funds tracked by Wall St. Rank hold MCRB as of Q2 2022.

Oregon Public Employees Retirement Fund reported no remaining Seres Therapeutics position as of Q2 2022 after selling out during the quarter.
Oregon Public Employees Retirement Fund sold 4,464 Seres Therapeutics shares in Q2 2022, an estimated $636K.
Oregon Public Employees Retirement Fund first reported a position in Seres Therapeutics in Q4 2020 and held it in 6 quarters.
Oregon Public Employees Retirement Fund's Seres Therapeutics position peaked at $2.19M in Q4 2020.
123 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2022.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2022, filed 25 Jul 2022.